In recent years, the biopharma industry has seen a surge of innovative companies, particularly in China. The momentum reflects the country’s strong commitments to biotechnology and medical development. Founded in 2015 or later, the companies highlighted here are diverse in their technological approaches and areas of expertise, yet are unified by their benchmarks of progress in the biopharma sector.
This article will introduce and explore companies headquartered in China that are making significant strides in the biopharma industry, from biotech startups reshaping the landscape of medical technology to pharmaceutical companies pioneering breakthroughs in drug development and precision medicine.
Let us draw attention to these industry leaders, acknowledging their advancements and contributions within the realm of biopharma. Herein are some of the promising biopharma companies operating out of China, displaying immense potential and promising developments in various realms of biological sciences and pharmaceuticals.
BiotechSino
Located in Suzhou, Jiangsu, China, BiotechSino is a biopharma company that was founded by Dai Kaifan. Although details on this company are scarce, it is evident that they operate in the realm of biotechnology and medical research.
ImmuneOnco Biopharma
Based in Shanghai, ImmuneOnco Biopharma was founded in June 2015 by Wenzhi Tian. The company is an early stage biopharmaceutical enterprise aiming to develop and commercialize novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and actively eradicate cancer cells.
Harbour Biomed
Harbour BioMed, co-founded by Frank Grosveld, Jeff He, Jingsong Wang, and Liang Schweizer, is a Shanghai-based company that focuses on bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company is dedicated to generating potential therapeutic antibodies and accelerating drug discovery and development.
Antengene Corporation
Founded by Jay Mei, Antengene Corporation is another addition to Shanghai’s growing biopharma scene. The company focuses on providing patients with innovative anti-tumor and anti-cancer therapies through new drug development, clinical research, and drug production.
Lyvgen Biopharma
Lyvgen Biopharma, founded by Jieyi Wang, is yet another promising biotech company based in Shanghai. They are known for their competency in creating a cross-linking-dependant antibody platform and for their particular focus on tumor immune agonistic antibody research.
Polaris Biology
Co-founded by Chao Zong, Li Zou, and Yuchong Wang, Polaris Biology is another noteworthy firm based in Shanghai. Known for their specialization in cell-level precision diagnostic technology, they are committed to using this information to support clinical tumor diagnosis and treatment.
Xinma Bio
Based in Shaoxing, Zhejiang, China, details about Xinma Bio and its founders are somewhat scant. Nevertheless, the company contributes to the country’s biotechnology and healthcare sectors.
Xynomic Pharmaceuticals
Located in Shanghai, Xynomic Pharmaceuticals was founded by Mark Xu. The company is primarily focused on in-licensing, developing and commercializing oncology drug candidates not only in China but also the US and the rest of the world.
Kelun Biotech
Based in Chengdu, Sichuan, China, Kelun Biotech is a biopharmaceutical company primarily focused on the research and development, production, and sales of innovative drugs.
Shanton Pharma
Established in 2016 by Koji Matsuyama, Shanghai-based Shanton Pharma is a biotechnology research organization dedicated to providing innovative therapies for addressing significant unmet medical needs.
Gloria spectrum
Lastly, Gloria Spectrum, based in Hangzhou, Zhejiang, is another representative of China’s dynamic biopharma industry, despite detailed information about the company currently being sparse.
Although diverse in their approaches and areas of expertise, these young companies are all contributing to the promising and vital biopharma industry located in China. Their fruitful endeavors in various realms of biotechnology, pharmaceutical research, and health care solutions are collectively shaping the future of medicine.
